| Literature DB >> 30403349 |
Thuy G Le1, Abhijit Kundu2, Atanu Ghoshal2, Nghi H Nguyen1, Sarah Preston3,4, Yaqing Jiao3, Banfeng Ruan1,5, Lian Xue6, Fei Huang6, Jennifer Keiser7,8, Andreas Hofmann9, Bill C H Chang3, Jose Garcia-Bustos3, Abdul Jabbar3, Timothy N C Wells10, Michael J Palmer10, Robin B Gasser3, Jonathan B Baell6,1.
Abstract
A phenotypic screen of a diverse library of small molecules for inhibition of the development of larvae of the parasitic nematode Haemonchus contortus led to the identification of a 1-methyl-1 H-pyrazole-5-carboxamide derivative with an IC50 of 0.29 μM. Medicinal chemistry optimization targeted modifications on the left-hand side (LHS), middle section, and right-hand side (RHS) of the scaffold in order to elucidate the structure-activity relationship (SAR). Strong SAR allowed for the iterative and directed assembly of a focus set of 64 analogues, from which compound 60 was identified as the most potent compound, inhibiting the development of the fourth larval (L4) stage with an IC50 of 0.01 μM. In contrast, only 18% inhibition of the mammary epithelial cell line MCF10A viability was observed, even at concentrations as high as 50 μM.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30403349 DOI: 10.1021/acs.jmedchem.8b01544
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446